CYFUSE BIOMEDICAL K KCYFUSE BIOMEDICAL K KCYFUSE BIOMEDICAL K K

CYFUSE BIOMEDICAL K K

No trades
See on Supercharts

4892 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Cyfuse Biomedical KK develops and manufactures cell regenerative systems. It focuses on developing arteries using patient's skin cells and three-dimensional (3D) printing. The firm's business activities encompass development, manufacturing, and sales of 3D tissue products. It also offers Regenova, a robotic system that facilitates the fabrication of 3D cellular structures by placing cellular spheroids in fine needle arrays according to pre-designed 3D data. The company was founded by Koji Kuchiishi and Koichi Nakayama on August 11, 2010 and is headquartered in Minato-ku, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

4892 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company